AUAUniversity Podcast Series: Episode No. 30

Chemo-ablation of Upper-Tract Urothelial Carcinoma

Co-Host: Vitaly Margulis, MD

At the conclusion of these activities, participants will be able to:
1. Identify new technologies for the treatment of urothelial carcinoma and analyze the risks and benefits of treatment.
2. Facilitate discussions with patients and caregivers regarding of urothelial carcinoma treatment options.

This educational series is supported by independent educational grants from:
Bristol-Myers Squibb
Genomic Health
Pfizer, Inc.
Sanofi Genzyme
UroGen Pharma